The global lumbar spinal pain management market size is expected to grow quickly in the future years for a variety of reasons, including the increasing prevalence of back pain, advancements in medical technology, and growing patient knowledge of available treatment choices. According to a recent market research analysis from Future Market Insights, the global market …
Author Archives: Editor AM
Barrett’s Esophagus with Dysplasia Treatment Market Envisions 5.3% CAGR Growth from 2023 to 2033-FMI Study
Over the coming years, a steady growth is anticipated in the global barrett’s esophagus with dysplasia treatment market. By 2033, its estimated value will be US$ 7.54 million. Growing public knowledge of the condition and available treatments, along with technological developments that have simplified the diagnosis and management of Barrett’s oesophagus, are the primary factors …
Stuttering Therapeutics Market Poised for Remarkable 14% CAGR Growth Through 2033-FMI Study
The global stuttering therapies market size is expected to increase at a compound annual growth rate (CAGR) of 14% between 2023 and 2033, according to a new industry research analysis from Future Market Insights. The industry is being driven by several factors, including increased knowledge and support for the illness, technology advancements, and the rising …
Radiotherapy Induced Oral Mucositis Treatment Market Envisions a Notable US$4.89 Billion Valuation in 2033-FMI Study
According to a new market research analysis published by Future Market Insights, the global radiotherapy induced oral mucositis treatment market is expected to rise at a compound annual growth rate (CAGR) of 5% between 2023 and 2033, reaching a market value of US$ 4.89 billion by that year. Radiotherapy-induced oral mucositis is a painful and …
Lupus Nephritis Treatment Market Sets Course for a Significant US$5.67 Billion Valuation by 2033-FMI Study
The lupus nephritis therapies market is expected to increase from current market size of US$ 1.8 billion in 2022 to US$ 5.67 billion by 2033, with a compound annual growth rate (CAGR) of 11% from 2023 to 2033. The disease’s increasing prevalence, more public awareness, and the emergence of innovative, cutting-edge treatments are all contributing …
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market Anticipates a Noteworthy US$4.89 Billion Valuation by 2033-FMI Study
With a compound annual growth rate (CAGR) of 5% from 2023 to 2033, the global focal segmentmental glomerulosclerosis (FSGS) therapeutics market is projected to reach a market size of US$ 4.89 billion by 2033 from US$ 3 billion in 2023. Focal Segmental Glomerulosclerosis (FSGS) Therapeutics saw a 3.5% compound annual growth rate (CAGR) in market …
Global PD1 Non-Small Cell Lung Cancer Treatment Industry is projected to hit a staggering worth of US$ 61 Billion by 2033, riding on an impressive CAGR of 8.51% | FMI
According to a recent study published by Future Market Insights, the global PD1 non-small cell lung cancer treatment industry size is slated to reach a valuation of US$ 26.96 Billion in 2023, and will further increase to US$ 61 Billion, registering a CAGR of 8.51% from 2023 to 2033. Rising prevalence of non-small cell lung …
Global Central Pain Syndrome Management Industry is expected to grow at a 5% CAGR, reaching US$ 100 Billion by 2033 | FMI
A recently published study by FMI expects the global central pain syndrome management industry size garnered a market value of US$ 60 Billion in 2023 to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the …
Global Pork Tapeworm Infection Treatment Industry will exceed US$ 25.17 Billion by 2033, with Albendazole Drugs positioned as the primary contenders | FMI Report
According to Future Market Insights, the global pork tapeworm infection treatment industry size is expected to reach US$ 11.66 Billion in 2023 to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion by 2033. It is expected that the market will further grow as the number of test kits and devices continues …
Global Drug Discovery Informatics Industry is expected to pursue a US$ 12.5 Billion target by 2033, driven by the data-centric evolution reshaping drug discovery | FMI
According to a recently published analytical report by Future Market Insights, the global drug discovery informatics industry size is expected to generate US$ 2.9 billion in sales by 2022. The market is predicted to reach a valuation of US$ 12.5 billion by 2033 with a CAGR of 14.4% from 2023 to 2033. With a CAGR …